Cover Image
市場調查報告書

發炎性皮膚疾病:全球臨床實驗檢討

Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 240558
出版日期 內容資訊 英文 46 Pages
訂單完成後即時交付
價格
Back to Top
發炎性皮膚疾病:全球臨床實驗檢討 Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015
出版日期: 2015年11月30日 內容資訊: 英文 46 Pages
簡介

本報告提供全球發炎性皮膚疾病治療藥物臨床實驗相關調查,不同地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 發炎性皮膚疾病
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗 , 各國
  • 對臨床實驗有所貢獻的主要國家 - 亞太地區
  • 對臨床實驗有所貢獻的主要國家 - 歐洲
  • 對臨床實驗有所貢獻的主要國家 - 北美
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 各階段臨床實驗
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 每段時期的實驗人數
  • 有力的贊助商
  • 參加主要企業 - 發炎性皮膚疾病 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 主要企業
  • Encore Pharmaceuticals, Inc.
  • 臨床實驗概要; Encore Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • 臨床實驗概要; Merck & Co., Inc.
  • GlaxoSmithKline plc
  • 臨床實驗概要; GlaxoSmithKline plc
  • Perrigo Company
  • 臨床實驗概要; Perrigo Company
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • 信州大學
  • 臨床實驗概要; 信州大學
  • SAINT LOUIS UNIVERSITY
  • 臨床實驗概要; SAINT LOUIS UNIVERSITY
  • Brigham and Women's Hospital
  • 臨床實驗概要; Brigham and Women's Hospital
  • Charite- Universitatsmedizin Berlin
  • 臨床實驗概要; Charite- Universitatsmedizin Berlin
  • The Johns Hopkins Bloomberg School of Public Health
  • 臨床實驗概要; The Johns Hopkins Bloomberg School of Public Health
  • Northwestern University
  • 臨床實驗概要; Northwestern University
  • New York University School of Medicine
  • 臨床實驗概要; New York University School of Medicine
  • Stanford University
  • 臨床實驗概要; Stanford University
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • About GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 臨床實驗 各地區
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 亞太地區, 主要國家
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 歐洲, 主要國家
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 北美, 主要國家
  • 發炎性皮膚疾病 治療藥物的臨床實驗, G7 各國
  • 發炎性皮膚疾病 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 各階段臨床實驗
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Encore Pharmaceuticals, Inc.
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Merck & Co., Inc.
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- GlaxoSmithKline plc
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Perrigo Company
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- 信州大學
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- SAINT LOUIS UNIVERSITY
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Brigham and Women's Hospital
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Charite- Universitatsmedizin Berlin
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- The Johns Hopkins Bloomberg School of Public Health
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Northwestern University
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- New York University School of Medicine
  • 發炎性皮膚疾病 治療藥物的臨床實驗市場, 全球市場、 臨床實驗- Stanford University

圖表一覽

圖表一覽

  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 臨床實驗 各地區 (%)
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 亞太地區, 主要國家 (%)
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 歐洲, 主要國家 (%)
  • 發炎性皮膚疾病 治療藥物的臨床實驗, G7 各國 (%)
  • 發炎性皮膚疾病 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 各階段臨床實驗 (%)
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 發炎性皮膚疾病 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 發炎性皮膚疾病 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3017CTIDB

GlobalData's clinical trial report, "Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Inflammatory Skin Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Skin Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Inflammatory Skin Diseases to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Inflammatory Skin Diseases to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Inflammatory Skin Diseases Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials by Region, 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Inflammatory Skin Diseases to Dermatology Clinical Trials, G7 Countries (%), 2015*
  • Inflammatory Skin Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Inflammatory Skin Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Inflammatory Skin Diseases to Dermatology Clinical Trials, E7 Countries (%), 2015*
  • Inflammatory Skin Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Inflammatory Skin Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Inflammatory Skin Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Inflammatory Skin Diseases to Dermatology Clinical Trials, G7 Countries (%), 2015*
  • Inflammatory Skin Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Inflammatory Skin Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Inflammatory Skin Diseases to Dermatology Clinical Trials, E7 Countries (%), 2015*
  • Inflammatory Skin Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Inflammatory Skin Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Inflammatory Skin Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Inflammatory Skin Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Inflammatory Skin Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top